- Increase in prevalence of hydrocephalus, rise in adoption of hydrocephalus shunt, and surge in incidences of neurological disorders drive the growth of the global hydrocephalus market.
PORTLAND, Ore., Jan. 19, 2022 /PRNewswire/ -- Allied Market Research published a report, titled, "Hydrocephalus Market by Cause (Congenital hydrocephalus and Acquired hydrocephalus), Type (Communicating hydrocephalus and non-communicating hydrocephalus), Diagnosis (CT scan, MRI, and Ultrasound), Treatment (Surgery Shunt Insertion and Ventriculostomy), and Age (Neonate & Pediatrics and Adults): Global Opportunity Analysis and Industry Forecast, 2021–2030." According to the report, the global hydrocephalus industry generated $6.90 billion in 2020, and is expected to reach $10.17 billion by 2030, witnessing a CAGR of 4.0% from 2021 to 2030.
For Right Perspective and Competitive Insights, Get Sample Report at: https://www.alliedmarketresearch.com/request-sample/15360
Drivers, restraints, and opportunities
Increase in prevalence of hydrocephalus, rise in adoption of hydrocephalus shunt, and surge in incidences of neurological disorders drive the growth of the global hydrocephalus market. However, shunt malfunctioning and related infections hinder the market growth. On the other hand, advancements in technology in the healthcare sector present new opportunities in the coming years.
Covid-19 Scenario
- Owing to lockdown restrictions and the possibility of cross-contamination, the patient flow was reduced substantially. However, the demand for advanced programmable shunts for the treatment of hydrocephalic patients is estimated to increase worldwide.
- The advent of disruptive technologies such as the "eShunt system" is estimated to boost the growth of the hydrocephalus market post-pandemic.
The acquired hydrocephalus segment to continue its dominance during the forecast period
Based on cause, the acquired hydrocephalus segment contributed to the highest share in 2020, accounting for more than half of the global hydrocephalus market, and is projected to continue its dominance during the forecast period. This is due to increase in neurological disorders and injuries such as intraventricular hemorrhage, stroke, tumor, and several other types of CSF infections that can result in the development of hydrocephalic conditions among patients. However, the congenital hydrocephalus segment is projected to witness the largest CAGR of 4.3% from 2021 to 2030.
Do You Have Any Query Or Specific Requirement? Ask to Our Industry Expert: https://www.alliedmarketresearch.com/purchase-enquiry/15360
The adults segment to continue its leadership status during the forecast period
Based on age, the adults segment accounted for the largest share in 2020, holding more than half of the global hydrocephalus market, and is expected to continue its leadership status during the forecast period. Moreover, this segment is projected to register the highest CAGR of 4.3% from 2021 to 2030. This is due to rise in the incidences of intraventricular hemorrhage or other brain injuries. The report also analyzes the neonate and pediatrics segment.
North America to continue its lead in terms of revenue by 2030
Based on region, North America held the highest market share in 2020, accounting for more than two-fifths of the global hydrocephalus market, and is expected to continue its lead in terms of revenue by 2030. This is due to rise in prevalence of the neurological disorder, increase in the number of hydrocephalus patients, development of advanced healthcare medical devices, and advancements in technology for hydrocephalus in the region. However, Asia-Pacific is expected to manifest the fastest CAGR of 5.0% during the forecast period. This is due to rise in awareness regarding minimally invasive surgeries, surge in cases of stroke and CSF related disorders, and technological advancements.
Leading Market Players
- Aesculap Inc.
- Integra Lifesciences
- Karl Storz Se And Co. Kg
- Proteses Inc.
- Medtronic Plc.
- Natus Medical Inc.
- Boston Children's Hospital
- Anadolu Medical Center
- Helios Hospital
- Texas Children's Hospital
- Children's National Hospital
Avenue Basic Plan | Library Access | 1 Year Subscription |
Sign up for Avenue subscription to access more than 12,000+ company profiles and 2,000+ niche industry market research reports at $699 per month, per seat. For a year, the client needs to purchase minimum 2 seat plan.
Request for 14 days free trial: https://www.alliedmarketresearch.com/avenue/trial/starter
"We have also published few syndicated market studies in the similar area that might be of your interest. Below are the report title for your reference, considering Impact of Covid-19 Over This Market which will help you to assess aftereffects of pandemic on short-term and long-term growth trends of this market."
Trending Reports in Healthcare Industry (Book Now with 10% Discount):
Hydrocephalus Shunts Market - Global Opportunity Analysis and Industry Forecast, 2020–2030
Global CT Scanners Market - Global Opportunity Analysis and Industry Forecast, 2020-2030
Ultrasound Devices Market - Global Opportunity Analysis and Industry Forecast, 2020-2030
MRI System Market - Global Opportunity Analysis and Industry Forecast, 2020–2030
Medical/Diagnostic Imaging Market - Global Opportunity Analysis and Industry Forecast, 2020–2030
Defibrillators Market - Global Opportunity Analysis and Industry Forecast, 2020–2030
Medical Tourism Market - Global Opportunity Analysis and Industry Forecast, 2020–2030
Molecular Diagnostics Market - Global Opportunity Analysis and Industry Forecast, 2020–2030
Single-use Bioprocessing Market - Global Opportunity Analysis and Industry Forecast, 2020–2030
Fertility Test Market - Global Opportunity Analysis and Industry Forecast, 2020–2030
About Us
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
Pawan Kumar, the CEO of Allied Market Research, is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
Contact:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com/reports-store/life-sciences
Follow Us on LinkedIn: https://www.linkedin.com/showcase/life-sciences-industry-research/
Logo: https://mma.prnewswire.com/media/636519/Allied_Market_Research_Logo.jpg
Share this article